Efficacy and safety of finerenone in patients with cardio-kidney-metabolic syndrome and history of cancer: the FINE-HEART pooled analysis

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Cardiorenal interactions and early therapeutic signals in acute heart failure Aldosterone Antagonists Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by